230 related articles for article (PubMed ID: 11578118)
41. Impaired bone marrow hematopoietic progenitor cell function in rheumatoid arthritis patients candidated to autologous hematopoietic stem cell transplantation.
Porta C; Caporali R; Epis O; Ramaioli I; Invernizzi R; Rovati B; Comolli G; Danova M; Montecucco C
Bone Marrow Transplant; 2004 Apr; 33(7):721-8. PubMed ID: 14743200
[TBL] [Abstract][Full Text] [Related]
42. A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts.
Yang H; Eaves C; de Lima M; Lee MS; Champlin RE; McMannis JD; Robinson SN; Niu T; Decker WK; Xing D; Ng J; Li S; Yao X; Eaves AC; Jones R; Andersson BS; Shpall EJ
Bone Marrow Transplant; 2006 Mar; 37(6):575-82. PubMed ID: 16435011
[TBL] [Abstract][Full Text] [Related]
43. Purging of leukemia-contaminated bone marrow grafts using suicide adenoviral vectors: an in vivo murine experimental model.
Garcia-Castro J; Rio P; Lillo R; Garcia-Sanchez F; Segovia JC; Bueren JA
Gene Ther; 2003 Aug; 10(16):1328-35. PubMed ID: 12883529
[TBL] [Abstract][Full Text] [Related]
44. Stem cell purging: an intriguing dilemma.
Rizzoli V; Carlo-Stella C
Exp Hematol; 1995 Apr; 23(4):296-302. PubMed ID: 7895779
[TBL] [Abstract][Full Text] [Related]
45. Purging with 4-hydroperoxycyclophosphamide combinations.
Jones RJ; Miller CB; Rowley SD
Prog Clin Biol Res; 1992; 377():1-9; discussion 10-1. PubMed ID: 1438406
[No Abstract] [Full Text] [Related]
46. Purging of murine erythroblastic leukemia by ZnPcS2P2-based-photodynamic therapy.
Huang HF; Chen YZ; Wu Y; Chen P
Bone Marrow Transplant; 2006 Jan; 37(2):213-7. PubMed ID: 16284611
[TBL] [Abstract][Full Text] [Related]
47. Pioglitazone inhibits the growth of human leukemia cell lines and primary leukemia cells while sparing normal hematopoietic stem cells.
Saiki M; Hatta Y; Yamazaki T; Itoh T; Enomoto Y; Takeuchi J; Sawada U; Aizawa S; Horie T
Int J Oncol; 2006 Aug; 29(2):437-43. PubMed ID: 16820887
[TBL] [Abstract][Full Text] [Related]
48. Differential binding of soybean agglutinin to human neuroblastoma cell lines: potential application to autologous bone marrow transplantation.
Reisner Y; Gan J
Cancer Res; 1985 Sep; 45(9):4026-31. PubMed ID: 2411394
[TBL] [Abstract][Full Text] [Related]
49. [Ex vivo and in vivo purging for PBSCT].
Moriyama Y
Rinsho Byori; 1999 May; Suppl 110():79-84. PubMed ID: 10475035
[TBL] [Abstract][Full Text] [Related]
50. Successful in vitro purging of leukemic blasts from marrow by cortivazol, a pyrazolosteroid: a preclinical study for autologous transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
Juneja HS; Harvey WH; Brasher WK; Thompson EB
Leukemia; 1995 Oct; 9(10):1771-8. PubMed ID: 7564524
[TBL] [Abstract][Full Text] [Related]
51. Neuroblastoma purging by immunorosette depletion.
Slaper-Cortenbach IC; de Vries-van Rossen A; Huijbens RJ; van Leeuwen EF; Figdor CG
Prog Clin Biol Res; 1992; 377():147-62. PubMed ID: 1438411
[No Abstract] [Full Text] [Related]
52. Purging of small cell lung cancer cells from bone marrow using immunomagnetic beads and a flow-through device.
Ball ED; Powers FJ; Vredenburgh JJ; Heath CA; Converse AO
Bone Marrow Transplant; 1991 Jul; 8(1):35-40. PubMed ID: 1655139
[TBL] [Abstract][Full Text] [Related]
53. [Purging of hemopoietic progenitor cells in autologous transplantation].
Hrubá A; Skala JP; Matĕjcková S; Fales I; Vodvárková S; Starý J; Kavan P; Kobylka P
Cas Lek Cesk; 1997 Mar; 136(5):151-3. PubMed ID: 9221189
[TBL] [Abstract][Full Text] [Related]
54. Elimination of malignant tumor cells from human bone marrow using monoclonal antibodies and immunomagnetic beads.
Wang SY; Makl KL; Chen LY; Tzeng CH; Hu CP; Chang C
Anticancer Res; 1993; 13(6A):2281-5. PubMed ID: 8297147
[TBL] [Abstract][Full Text] [Related]
55. Deferoxamine as a purging agent for autologous bone marrow grafts in neuroblastoma.
Skala JP; Rogers PC; Chan KW; Chao HY; Rodriguez WC
Prog Clin Biol Res; 1992; 377():71-8. PubMed ID: 1438447
[No Abstract] [Full Text] [Related]
56. Clinical protocol. Purging of autologous stem cell sources with bcl-x(s) adenovirus for women undergoing high-dose chemotherapy for stage IV breast carcinoma.
Ayash LJ; Clarke M; Adams P; Ferrara J; Ratanatharathorn V; Reynolds C; Roessler B; Silver S; Strawderman M; Uberti J; Wicha M
Hum Gene Ther; 2001 Nov; 12(16):2023-5. PubMed ID: 11727734
[TBL] [Abstract][Full Text] [Related]
57. Tumour cell purging for autologous bone marrow transplantation.
Trickett AE
Med Lab Sci; 1990 Apr; 47(2):120-31. PubMed ID: 2199741
[TBL] [Abstract][Full Text] [Related]
58. [Role of marrow purging].
Rizzoli V; Carlo-Stella C; Mangoni L
Haematologica; 1991 Jun; 76 Suppl 3():311-20. PubMed ID: 1684346
[No Abstract] [Full Text] [Related]
59. Selective elimination of malignant stem cells using photosensitizers followed by light treatment.
Levy JG; Dowding C; Mitchell D; Sorrenti R; Yip S; Jamieson C
Stem Cells; 1995 Jul; 13(4):336-43. PubMed ID: 7549891
[TBL] [Abstract][Full Text] [Related]
60. [Effect of immunomagnetic selection in purging autologous peripheral blood progenitor cell of breast cancer patients].
Han X; Shi Y; Zhang W
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):203-6. PubMed ID: 11953162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]